Chemical Structure (Dantrium Iv 1)
Dantrium Injection
Product Images NDC 42023-123
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dantrium (NDC 42023-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (20 mg Vial Carton)
This text contains information about the prescription drug Dantrium Intravenous, used for the treatment of malignant hyperthermia. Each vial contains a sterile lyophilized mixture of 20 mg dantrolene sodium, 3,000 mg mannitol, and sufficient sodium hydroxide to yield a pH of approximately 9.5 when reconstituted with 60 mL sterile water. The text also includes instructions for the preparation of the solution for intravenous use, warnings about drug compatibility and usage, and the manufacturer's information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
